Of the reported PD-associated PINK1 mutations, about 30 of them are defined as “pathogenic” or “likely pathogenic,” causing similar clinical symptoms as in the cases caused by Parkin mutations (Richards et al., 2015; Ellard et al., 2020). This evidence concerns the gene PRKN and Parkinson disease.